南澳大利亚活检阳性巨细胞动脉炎患者的急诊就诊与住院负担
基于南澳大利亚GCA登记库(1992-2022)的回顾性队列研究,纳入435例活检阳性GCA患者与2124例对照,链接2001-2022年急诊与住院数据。GCA患者急诊就诊(HR 1.74,95%CI 1.48–2.03)和住院(HR 1.73,95%CI 1.14–2.61)风险显著增加,事件多集中在诊断后12个月内,且感染、脑血管病、骨质疏松/骨折、肺栓塞、憩室炎和动脉粥样硬化相关住院风险升高。
要点
- 活检阳性GCA患者急诊与住院风险均显著高于对照,事件高峰在诊断后12个月内。
- GCA患者因感染、脑血管病、骨质疏松/骨折、肺栓塞、憩室炎和动脉粥样硬化住院的风险更高。
- GCA患者与对照的累积Elixhauser共病评分无显著差异(年龄校正均值差-0.1,p=0.59)。
核心结论
- 活检阳性GCA患者急诊就诊和住院风险显著增加,尤其在诊断后12个月内疾病负担最重。
研究设计与样本
- 从南澳大利亚GCA登记库(1992-2022)纳入年龄≥50岁颞动脉活检阳性患者,按4:1匹配同一社会人口学分布的对照,链接2001-2022年急诊和住院数据。
- 采用复发事件Andersen-Gill时间-事件模型估计风险比(HR),并在末次访视时计算累积Elixhauser共病评分。
主要发现
- 共纳入435例GCA患者和2124例对照。
- GCA患者急诊就诊风险升高(HR 1.74,95%CI 1.48–2.03),住院风险亦升高(HR 1.73,95%CI 1.14–2.61),事件在诊断后12个月内最多。
- GCA患者平均住院时长与对照相当。
- GCA患者主要住院诊断中感染(HR 1.53,95%CI 1.12–2.09)、脑血管病(HR 1.99,95%CI 1.17–3.36)、骨质疏松/骨质疏松性骨折(HR 4.0,95%CI 1.06–15.08)、肺栓塞(HR 4.35,95%CI 1.53–12.27)、憩室炎(HR 4.74,95%CI 1.12–2.09)和动脉粥样硬化(HR 9.73,95%CI 3.22–29.4)风险升高。
- 累积Elixhauser共病评分在GCA患者与对照间无差异(年龄校正均值差-0.1,p=0.59)。
临床怎么用
- 对活检阳性GCA患者,尤其在诊断后12个月内,应关注急诊就诊和住院风险,加强感染、脑血管病、骨质疏松/骨折、肺栓塞、憩室炎和动脉粥样硬化的监测与管理。
局限性
- 本研究为澳大利亚单地区登记库的回顾性队列研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: Giant cell arteritis (GCA) causes significant morbidity from disease burden and treatment complications, yet Australian data on healthcare utilisation are lacking. This study quantified healthcare utilisation among patients with biopsy-proven GCA in South Australia (SA) by examining rates and causes of hospitalisation and emergency department (ED) presentation, temporal trends, length of stay, and cumulative comorbidity burden. METHODS: Patients aged ≥50 years with positive temporal artery biopsy were identified from the SA GCA Registry (1992-2022). ED presentations and hospital admissions (2001-2022) were obtained using the SA-NT Data-linkage framework, and compared against controls (4:1) from the same sociodemographic distribution. Recurrent event Andersen-Gill time-to-event models estimated Hazard Ratios (HR). Cumulative Elixhauser comorbidity scores were determined at last visit as a surrogate for patients' overall health status. RESULTS: 435 GCA patients and 2124 controls were included. Both ED presentations and hospital admissions were increased in GCA patients compared to controls (HR 1.74 (95%CI 1.48, 2.03) and HR 1.73 (95%CI 1.14, 2.61)), with events highest within 12 months of GCA diagnosis. Mean length of stay was equivalent. GCA patients more often had a principal admission diagnosis of infection (HR 1.53, 95%CI 1.12, 2.09), cerebrovascular disease (HR 1.99, 95%CI 1.17, 3.36), osteoporosis/osteoporotic fracture (HR 4.0, 95%CI 1.06, 15.08), pulmonary embolus (HR 4.35, 95%CI 1.53, 12.27), diverticulitis (HR 4.74, 95%CI 1.12, 2.09), and atherosclerosis (HR 9.73, 95%CI 3.22, 29.4). Comorbidity index suggested no difference between GCA patients and controls (age-adjusted mean difference =-0.1, p = 0.59). CONCLUSION: This is the first Australian study to determine the significant burden of GCA, particularly in the 12 months following diagnosis. Improved understanding of healthcare utilisation will enable appropriate resource allocation and research prioritisation to improve patient outcomes.
引用
- Lyne SA, Lester S, Stanhope J, et al. Emergency department presentations and hospital admissions for patients with biopsy-positive giant cell arteritis in South Australia. Semin Arthritis Rheum. 2026. PMID: 41903314. doi:10.1016/j.semarthrit.2026.152970
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。